Healthcare

United States Molecular Point-of-Care Testing Growth Opportunities

Syndromic Point-of-Care Testing Drives Transformational Growth in Infectious Disease Diagnostics


RELEASE DATE
14-Jul-2022
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
PCF1-01-00-00-00
SKU
HC03562-NA-MT_26707
Yes
SHARE

United States Molecular Point-of-Care Testing Growth Opportunities
Published on: 14-Jul-2022 | SKU: HC03562-NA-MT_26707

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Rapid advancements in infectious disease diagnostics continue with novel identification methods and healthcare accessibility improvements. The shift from traditional testing to a more technologically empowered, consumer-centric testing encompasses the sample-in-answer-out approach of diagnostic testing that generates results in minutes or hours. Nucleic acid amplification technologies meeting the criteria for point of care or designated as moderately complex tests to detect single or multiple pathogens have transformed the requirements for test sensitivity, specificity, and turnaround time.

A personalized medicine and treatment program that establishes clinical treatment plans for infectious diseases on a patient-by-patient basis is a hot topic of discussion in clinical microbiology and virology. Molecular diagnostic technologies, such as polymerase chain reaction and other nucleic acid-based amplification technologies, gradually replace or improve traditional laboratory techniques for pathogen identification through point-of-care tests. The driving force enabling this shift stems from the ability of point-of-care tests to detect microorganisms indicating possible poly-microbial infection.

State-of-the-art molecular point-of-care testing for infectious diseases enables physicians to make early evidence-based treatment decisions. Many of these tests have received waiver from the Clinical Laboratory Improvement Amendments and are easy to use. The diagnostics industry is moving toward comprehensive syndromic tactics, simultaneously detecting multiple pathogens with overlapping clinical syndromes.

The growing need for syndromic point-of-care testing propels leading companies in the in vitro diagnostics space to prioritize pipeline expansion and fortify their partnerships. With consumers increasingly monitoring their health and wellness, test developers will explore innovative methods to change the care delivery paradigm. The paradigm shift could create new channels to deliver consumer-grade offerings, expand access to high-quality laboratory testing, and empower individuals to take charge of their health and well-being.

This Frost & Sullivan study sheds light on the US molecular point-of-care testing industry, identifying three key growth opportunities by assessing the industry’s instruments/platforms, consumables (assays and kits), regulatory environment, emerging business models, and revenue forecasts.

Analyst: Amartya Bose

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Molecular Point-of-Care Testing Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Key Competitors

Growth Metrics

Growth Drivers

Growth Restraints

Forecast Assumptions

Revenue Forecast—Aspirational Scenario

Revenue Forecast—Conservative Scenario

Revenue Forecast—Frost & Sullivan’s Scenario

Revenue Forecast by Segment

Revenue Forecast Analysis

Pricing Trends and Forecast Analysis

Competitive Environment

Revenue Share

Revenue Share Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast Analysis

Growth Opportunity 1—Small to Midsize Syndromic Panels for Predefined Infectious Disease Pathogens

Growth Opportunity 1—Small to Midsize Syndromic Panels for Predefined Infectious Disease Pathogens (continued)

Growth Opportunity 2—Rapid PCR POC and At-home Testing Platforms

Growth Opportunity 2—Rapid PCR POC and At-home Testing Platforms (continued)

Growth Opportunity 3—DTC Multi-analyte Testing Services

Growth Opportunity 3—DTC Multi-analyte Testing Services (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

List of Figures
  • Molecular POCT: Growth Metrics, US, 2021 2026
  • Molecular POCT: Growth Drivers, US, 2022 2026
  • Molecular POCT: Growth Restraints, US, 2022 2026
  • Molecular POCT: Revenue Forecast Aspirational Scenario, US, 2020 2026
  • Molecular POCT: Revenue Forecast Conservative Scenario, US, 2020 2026
  • Molecular POCT: Revenue Forecast Frost & Sullivan’s Scenario, US, 2020 2026
  • Molecular POCT: Revenue Forecast by Segment, US, 2020 2026
  • Molecular POCT: Revenue Share of Top Participants, US, 2021
  • Consumables: Growth Metrics, US, 2021 2026
  • Consumables: Revenue Forecast, US, 2020 2026
  • Instruments/Platforms: Growth Metrics, US, 2021 2026
  • Instruments/Platforms: Revenue Forecast, US, 2020 2026

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Information Technology research

16 Nov 2026   |   Global   |   Customer Research

A View Into UCC Purchase Power Beyond IT Decision-Makers

The growing influence of business stakeholders on technology decisions is reshaping how organizations evaluate, purchase, and deploy communications and collaboration solutions. While IT departments remain central to technology governance, security, and infrastructure planning, communications technol...

16 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: AI Governance Platforms, 2026

Enterprise AI governance is entering a new phase as organizations move beyond isolated models and generative AI applications toward increasingly complex portfolios of models, agents, copilots, workflows, and third-party AI services. The evolution is expanding governance requirements beyond policy ma...

13 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: North American UCaaS and Cloud-Connected Calling Providers, 2026

The North American UCaaS and cloud-connected calling market continues to present growth opportunities despite increasing maturity and competitive intensity. Ongoing cloud migrations, hybrid work requirements, and demand for modern communications technologies will sustain market expansion, although s...

11 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Voice of Customer Analytics, 2026

Businesses receive massive amounts of customer feedback every day through eCommerce platforms, customer support calls, emails, social media platforms, bots, and chats. This presents an opportunity to enhance market intelligence. Voice of customer (VoC) refers to the practice of collecting, analyzing...

05 Nov 2026   |   Global   |   Customer Research

Growth Opportunities in AI-Powered Communications

This research report examines the growth opportunities emerging from artificial intelligence-powered unified communications and collaboration (UCC), drawing on Frost & Sullivan’s 2026 global survey of 1,198 IT and business decision-makers across North America, Latin America, Europe, and Asia-Pacific...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.